Development of Quality Metrics to Evaluate Pediatric Hematologic Oncology Care in the Outpatient Setting

Jennifer Teichman1, Angela Punnett, Sumit Gupta

  • 1*Undergraduate Medical Education, Faculty of Medicine, University of Toronto †Department of Pediatrics, Division of Hematology/Oncology, The Hospital for Sick Children, Toronto, ON, Canada.

Insights

This study developed quality of care metrics for pediatric oncology clinics. A consensus process identified 13 key metrics for improving leukemia-lymphoma (LL) clinic patient care.

Area of Science:

  • Pediatric Oncology
  • Quality Improvement Science
  • Health Services Research

Background:

  • No standardized clinic-level quality of care metrics exist for outpatient pediatric oncology.
  • Developing such metrics is crucial for enhancing patient care and outcomes in specialized clinics.

Purpose of the Study:

  • To develop a consensus-based list of quality of care metrics for a pediatric leukemia-lymphoma (LL) clinic.
  • To establish a replicable model for quality metric development adaptable to other pediatric oncology settings.

Main Methods:

  • Systematic literature search of Medline-Ovid for pediatric oncology quality indicators.
  • Two-round Delphi process involving a Consensus Group (CG) of LL clinic staff.
  • Consensus defined as ≥70% agreement within 2 consecutive ranking scores.

Main Results:

  • Initial review generated 27 metrics; 19 reached consensus in Round 1.
  • Round 2 included 31 metrics (revised and new), with 24 reaching consensus (77%).
  • A final list of 13 key metrics was selected, covering patient communication, pain management, access to psychology, documentation, and treatment timeliness.

Conclusions:

  • A validated set of 13 quality metrics for pediatric LL clinics was successfully developed using a consensus process.
  • This methodology provides a transferable model for quality metric development and implementation in other pediatric oncology settings.
  • The identified metrics will guide ongoing quality improvement initiatives within the LL clinic.

Related Concept Videos

Standards of Care II01:19

Standards of Care II

Nurses bear specific legal responsibilities under several federal statutes, including:
1.2K
Bone Marrow Sampling and Transplants01:22

Bone Marrow Sampling and Transplants

Bone marrow transplant is a potential cure for several diseases, including cancer and specific genetic disorders. Notably, this procedure is applicable for patients suffering from aplastic anemia, certain types of leukemia, severe combined immunodeficiency disease (SCID), Hodgkin's disease, non-Hodgkin's lymphoma, multiple myeloma, thalassemia, sickle-cell disease, and certain cancers.
The transplant begins with high doses of chemotherapy and radiation treatment, which aim to destroy...
2.2K
Standards of Care I01:22

Standards of Care I

Federal statutes profoundly impact nursing practice, providing critical guidelines to ensure patient care is equitable, accessible, and of the highest quality. The following laws address distinct aspects of healthcare provision and patient rights:
1.3K
Guidelines for Writing Outcome01:11

Guidelines for Writing Outcome

When developing expected outcomes for a patient care plan, the nurse should adhere to the following recommendations:
Patient outcomes reflect the patient's response to the goal rather than what the nurse aims to achieve. Terminology should be observable and measurable to avoid the reader's interpretation. The desired outcome should be realistic and achievable in the designated care timeframe. Expected outcomes should align with adjunctive therapies. The outcome should enhance care...
4.2K
Pharmacokinetics in Pediatric Patients: Drug Excretion01:26

Pharmacokinetics in Pediatric Patients: Drug Excretion

In pediatric medicine, understanding the renal function and drug elimination nuances is crucial for administering safe and effective treatments. Newborns, in particular, display markedly slower renal functions than adults, profoundly affecting how drugs are cleared from their bodies. This slower drug clearance requires clinicians to extend the dosing intervals for many medications to prevent drug accumulation and toxicity while ensuring therapeutic efficacy.One key area where these adjustments...
354
Pharmacokinetics in Pediatric Patients: Drug Distribution01:17

Pharmacokinetics in Pediatric Patients: Drug Distribution

Drug distribution in the pediatric population exhibits unique challenges and considerations due to the physiological differences between children, particularly neonates and infants, and adults. A crucial aspect of pediatric pharmacology is understanding how these differences impact the pharmacokinetics of various drugs, necessitating age-specific dosing strategies to ensure efficacy and safety.Neonates and infants have a higher total body water content, ~75%–90% of their body weight,...
419